Cargando…
Considerations for a Respiratory Syncytial Virus Vaccine Targeting an Elderly Population
Respiratory syncytial virus (RSV) is most commonly associated with acute lower respiratory tract infections in infants and children. However, RSV also causes a high disease burden in the elderly that is often under recognized. Adults >65 years of age account for an estimated 80,000 RSV-associated...
Autores principales: | Stephens, Laura M., Varga, Steven M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228432/ https://www.ncbi.nlm.nih.gov/pubmed/34207770 http://dx.doi.org/10.3390/vaccines9060624 |
Ejemplares similares
-
Function and Modulation of Type I Interferons during Respiratory Syncytial Virus Infection
por: Stephens, Laura M., et al.
Publicado: (2020) -
Development of Respiratory Syncytial Virus Vaccine Candidates for the Elderly
por: Blanco, Jorge C. G., et al.
Publicado: (2023) -
Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines
por: Topalidou, Xanthippi, et al.
Publicado: (2023) -
The road to approved vaccines for respiratory syncytial virus
por: Ruckwardt, Tracy J.
Publicado: (2023) -
Respiratory Syncytial Virus Infection in Elderly Adults
por: Falsey, Ann R., et al.
Publicado: (2012)